Ticker Details
Exagen Inc.
IPO Date:	September 20, 2019
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$105.34M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.32 | 4.01%
Avg Daily Range (30 D):	$0.25 | 5.52%
Avg Daily Range (90 D):	$0.17 | 4.55%

Institutional Daily Volume
Avg Daily Volume:	.09M
Avg Daily Volume (30 D):	.28M
Avg Daily Volume (90 D):	.33M

Trade Size
Avg Trade Size (Sh.):	105
Avg Trade Size (Sh.) (30 D):	89
Avg Trade Size (Sh.) (90 D):	97

Institutional Trades
Total Institutional Trades:	75
Avg Institutional Trade:	$1.72M
Avg Institutional Trade (30 D):	$.57M
Avg Institutional Trade (90 D):	$.6M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.09M
Avg Closing Trade (30 D):	$.57M
Avg Closing Trade (90 D):	$.6M
Avg Closing Volume:	208.08K

News

Feb 24, 2026 @ 2:00 PM Exagen Inc. to Announce Fourth Quarter and Full Ye... Source: Na

Jan 11, 2026 @ 8:00 PM Exagen Inc. Announces Select Preliminary 2025 Fina... Source: Na

Nov 11, 2025 @ 2:00 PM Exagen Inc. to Participate in Fourth Quarter Inves... Source: Ryan Douglas

Jun 13, 2024 @ 12:50 PM Why Fast-paced Mover Exagen (XGN) Is a Great Choic... Source: Zacks Equity Research

Jun 10, 2024 @ 12:03 PM Time to Play 5 Top-Ranked Stocks With Rising P/E? Source: Sanghamitra Saha

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.89	$-.17	$-.2
Diluted EPS	$-.89	$-.17	$-.2
Revenue	$68.38M	$17.31M	$16.63M
Gross Profit	$39.88M	$10.21M	$9.21M
Net Income / Loss	$-20.17M	$-3.97M	$-4.67M
Operating Income / Loss	$-14.12M	$-3.41M	$-4.98M
Cost of Revenue	$28.5M	$7.1M	$7.43M
Net Cash Flow	$10.32M	$-10.71M	$-3.43M
PE Ratio